Wolverine Trading, LLC Eli Lilly & CO Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $117 Million - $146 Million	151,900 Added 44.87%	490,400 $434 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $8.48 Million - $10.6 Million	11,700 Added 3.58%	338,500 $306 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $19.4 Million - $26 Million	-32,800 Reduced 9.12%	326,800 $254 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $15.2 Million - $18 Million	29,000 Added 8.77%	359,600 $210 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $10.7 Million - $14.8 Million	24,700 Added 8.07%	330,600 $178 Million
Q2 2023 Aug 23, 2023	BUY	$350.74 - $468.98 $8.14 Million - $10.9 Million	23,200 Added 8.21%	305,900 $143 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $24.6 Million - $28.9 Million	79,300 Added 38.99%	282,700 $96.3 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $65.4 Million - $76.2 Million	203,400 New	203,400 $74.4 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.03 Million - $1.21 Million	3,700 Added 2.76%	137,900 $44.5 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.94 Million - $4.9 Million	16,800 Added 14.31%	134,200 $38.9 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $13 Million - $16.1 Million	57,800 Added 96.98%	117,400 $32.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $79.6 Million - $97.9 Million	-359,000 Reduced 85.76%	59,600 $13.7 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $55.1 Million - $71.2 Million	305,000 Added 268.49%	418,600 $96 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $6.56 Million - $8.49 Million	39,900 Added 54.14%	113,600 $21.1 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $821,898 - $1.09 Million	6,300 Added 9.35%	73,700 $12.3 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $5.47 Million - $6.33 Million	-37,400 Reduced 35.69%	67,400 $9.86 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $9.59 Million - $11.5 Million	-70,300 Reduced 40.15%	104,800 $17.1 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $3.61 Million - $4.46 Million	-30,300 Reduced 14.75%	175,100 $24.2 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $748,440 - $927,010	7,000 Added 3.53%	205,400 $27 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $2.54 Million - $2.76 Million	-23,800 Reduced 10.71%	198,400 $22.3 Million
Q2 2019 Aug 20, 2019	SELL	$110.79 - $129.32 $17.3 Million - $20.1 Million	-155,700 Reduced 41.2%	222,200 $24.6 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $14.5 Million - $17 Million	130,000 Added 52.44%	377,900 $49 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $6.93 Million - $7.76 Million	65,400 Added 35.84%	247,900 $28.3 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $2.54 Million - $3.18 Million	29,600 Added 19.36%	182,500 $19.6 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $3.27 Million - $3.85 Million	44,000 Added 40.4%	152,900 $11.8 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $8.92 Million - $9.57 Million	108,900	108,900 $9.2 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.2 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$27 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account